Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/14242
DC FieldValueLanguage
dc.contributor.authorIrena Kafedziskaen_US
dc.contributor.authorMishevska Perchinkova, Snezhanaen_US
dc.contributor.authorAntova, Dubravkaen_US
dc.contributor.authorKotevska Nikolova, Mimozaen_US
dc.contributor.authorStojanovska, Anzhelikaen_US
dc.contributor.authorGuchev, Filipen_US
dc.date.accessioned2021-07-29T11:25:49Z-
dc.date.available2021-07-29T11:25:49Z-
dc.date.issued2020-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/14242-
dc.language.isoenen_US
dc.publisherScience Publishing Groupen_US
dc.relation.ispartofAmerican Journal of Internal Medicineen_US
dc.titleMulticenter, Open-Label, Long-term Extension to Describe the Safety of Tocilizumab in Patients with Early, Moderate to Severe Rheumatoid Arthritisen_US
dc.typeArticleen_US
dc.identifier.doi10.11648/j.ajim.20200803.16-
dc.identifier.urlhttp://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20200803.16.pdf-
dc.identifier.volume8-
dc.identifier.issue3-
dc.identifier.fpage125-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

86
checked on 20.7.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.